You notice new thigh pain, find it harder to get up from a chair and remember that you recently started taking a statin. The possible connection is worth reporting, but two events close together in time do not establish a cause. As a runner, you also need to describe recent exertion, other medicines and changes in everyday life. The appropriate next step is timely medical assessment of the symptom and an individual review of treatment.
Seek medical care without delay for unusually severe muscle pain, substantial weakness or dark urine; not all signs need to appear together. The CDC information on rhabdomyolysis explains that symptoms of muscle breakdown may resemble other conditions and may develop later too. For severe illness, fainting or difficulty breathing, call 112. Logging the symptom, entering a rest day or waiting until the next routine review is not enough in these situations.
Why was a statin included in your treatment?
Statins are cholesterol-lowering medicines used, among other purposes, to prevent cardiovascular events. The NHS overview mentions both preventing a first event and treatment with existing cardiovascular disease. Your individual benefit does not depend simply on whether you run. Know which history or risk led to your prescription and what the treatment aims to achieve.
You do not need to recalculate this mentally from a running log. Good endurance and the need for preventive medication are separate questions. If muscle symptoms worry you, both belong in the discussion: how to investigate the symptom and how to keep cardiovascular risk management on track. The aim is neither to conceal an uncomfortable symptom nor to disregard the reason for prescribing.
The UK medicines regulator MHRA’s information on benefits and risks says muscle symptoms call for treatment review, considering history, symptom severity and possible interactions. This information dates from 2014; we do not use its old frequency figures as a current personal risk estimate. The principle is clear, however: symptoms need assessment, and decisions about medication are healthcare tasks.
Pain and weakness deserve separate descriptions
“Muscle symptoms” is a broad term. Explain whether an area hurts, feels tender, cramps, feels heavy or is genuinely harder to use. “I’m running more slowly” alone does not reveal the difference. If stairs, standing up or holding familiar objects have become harder, report those everyday changes too. Describe your own observations rather than naming a muscle disorder in advance.
Also identify the location and extent: whether it is one spot, several muscle groups, one side or both. Do not devise a provocative strength test to prove the symptom is real. Your care provider needs an account of its appearance and changes, not a pain challenge performed at home. Do not delay reporting deterioration or an unusually severe symptom to collect a few more days of comparative data.
A useful sentence might be: “I have new weakness in both thighs on stairs that used to be routine; this is when it began and how it has changed.” That is more precise than “I definitely have statin intolerance”. Neutral description does not minimise the experience. It helps several possible explanations be examined and prevents the symptom getting lost behind a predetermined label.
Enlarge imageA timeline says more than one suspicion
Make a brief timeline of starting the medicine or a prescribed change, first noticing the symptom and significant exertion. If the exact date is unknown, mark it as approximate. The log is not intended to prove causation on its own. It shows which events preceded the symptom and which questions need clarification.
| Timeline element | What should you record? | What should you not automatically conclude? |
|---|---|---|
| Treatment | The product name and known time of starting or changing it. | The medicine caused every symptom that followed. |
| Exertion | Unusual training, a race or heavy physical work. | Every muscle pain after sport is harmless. |
| Symptom | Location, character, everyday effects and change. | Pain intensity alone completes the diagnosis. |
| Another change | A new medicine, illness or supplement. | An over-the-counter product is definitely irrelevant. |
Make the medication list complete. It includes a new antibiotic alongside the statin, other regular or occasional medicines, herbal products and sports supplements. According to the NHS, some medicines and other products can increase side-effect risk or alter treatment effects. You do not need to decide on interactions at home: give the exact names and ingredients to a doctor or pharmacist.
Having taken the same medicine without symptoms previously does not rule out a connection either. The present change needs assessment with your current history. Equally, a new workout coinciding with a new tablet does not establish each one’s role. Do not try to distinguish possible causes through your next hard run. Clinical assessment does not require recreating illness at home.
What is a CK test for, and what is it not for?
Creatine kinase, or CK, is an enzyme present in muscle cells among other places. The MedlinePlus test information explains that more can enter the blood when muscles are damaged; strenuous physical activity can also affect its level. A result is assessed together with history, symptoms and repeat tests where necessary. The CK number alone does not reliably identify the cause of a symptom.
The NICE NG238 recommendations describe seeking medical advice and assessing CK for unexplained muscle pain, tenderness or weakness when monitoring statin treatment. The guideline’s professional thresholds are not rules for medication decisions at home. Ask what investigations are planned, how to prepare and who will interpret the result. Clarify preparation with the provider requesting the test.
If you did substantial exercise or heavy physical work before the blood test, say so. Do not conceal it for fear that your symptom will then not be taken seriously. Such information helps correct interpretation. Equally, do not independently try to “produce a good result” through a self-selected period without exercise: discuss the necessary preparation and timing as part of your care.
What do blinded trials teach us about interpreting symptoms?
The Cholesterol Treatment Trialists’ Collaboration’s 2022 participant-level analysis included data from 123940 people in 19 double-blind trials comparing a statin with placebo. During follow-up, 27.1 per cent of the statin group and 26.6 per cent of the placebo group reported muscle pain or weakness. The analysis published in The Lancet found a small excess, while many symptoms occurred in both groups. These trial-group proportions are not an individual runner’s diagnosis.
The lesson has two parts. Saying statins never cause muscle symptoms is inaccurate. Saying every muscle pain during treatment is definitely caused by them is inaccurate too. Comparative trials help distinguish symptoms that occur in the background anyway from an excess attributable to medication. An individual situation still needs personal assessment and history.
This result is not a reason to dismiss a symptom. The symptom is real even if the medicine did not cause it. Conversely, the small average difference in a large study cannot rule out rare, severe muscle breakdown. Urgent signs and care for new, unexplained symptoms take priority over asking which statistical group a reader resembles.
Individual investigation is not a home medication experiment either
StatinWISE examined alternating, randomly ordered, double-blind statin and placebo periods in people who had previously reported muscle symptoms. For the main analysis, 151 participants supplied symptom data from both types of period; no clear group-level difference in symptom scores was found. The 2021 BMJ paper describes clinically organised research, not patients independently switching medication on and off.
In the blinded design, participants did not know which preparation they received during each period. This fundamentally differs from stopping a medicine, changing running and then attributing every improvement to withdrawal. Several factors can change together in everyday life. A clinician-recommended treatment review should therefore have a known purpose and follow-up; you do not need to organise your own control group or secret test.
Uncertainty can be discussed without stigma. You can ask which other causes need investigating, which tests may help and what the treatment plan is if symptoms persist. A difference not demonstrated at group level does not mean a medication effect is impossible in every individual. Acknowledging personal symptoms and carefully assessing causation support one another.
Enlarge imageHow should you report symptoms to your care providers?
Do not wait until the next general screening appointment with a new, unexplained muscle symptom. When making contact, say you take a statin, what occurred, when it began and whether there is weakness or a change in urine. Keep your medication list available. If the symptom is severe, rapidly worsening or urgent, state that in your first sentence rather than at the end of the training details.
The title’s advice not to stop independently does not mean you must continue unchanged until the next routine appointment despite severe symptoms. It means obtaining appropriate medical help without delay and receiving medication instructions from your care provider in line with your own product’s safety information. If you have already changed something, say exactly what; do not conceal it because you have since become uncertain.
The NHS describes checking the cause of a suspected side effect and, if necessary, clinician-directed changes to treatment. Do not choose a different statin or dose based on a running group’s suggestion. Leftover tablets from an earlier prescription are not an independent replacement option either. The specific solution depends on the findings, preventive treatment you need and what you can tolerate.
Ask about running as well as the tablet
During assessment of the symptom, separately clarify which activity may be considered in the meantime. Not needing a home medication experiment does not mean running through pain is supported. If familiar movement causes a new symptom, do not repeatedly test it at race pace. Individual activity guidance and the conditions for the next review should form part of the discussion.
A fictional example: a runner started a new medicine, did an unusual strength session around the same time and then developed muscle symptoms. They bring the three events to the appointment on a timeline rather than choosing a single cause in advance. They ask whether investigations are needed, what to do about training and when to get back in touch. If pronounced weakness or dark urine develops, they do not wait for the story to become complete but seek immediate care.
Briefly record the review’s outcome: the instructions for treatment, activity and follow-up. You can then give your coach a clear framework without leaving them to decide about medication. The useful goal is for symptoms to receive real attention, the reason for preventive treatment to remain in view and neither decision to be determined by a single run or a laboratory value interpreted alone.
Sources
- CDC: Signs and Symptoms of Rhabdomyolysis
- NHS: Statins
- MHRA: Statins – benefits and risks
- MedlinePlus: Creatine Kinase Test
- NICE NG238: Cardiovascular disease – recommendations
- CTT Collaboration: Effect of statin therapy on muscle symptoms, 2022
- Herrett and colleagues: StatinWISE, 2021
How Futószív articles are prepared: our editorial guidelines.


